Endovascular approach for arteriovenous limb malformations: a single center experience

Bissacco, Daniele; Barbosa, Fernando Policarpo; Castronovo, E.; Alfonsi, A; Solcia, Marco; Rampoldi, Antonio

doi:10.23736/s0392-9590.21.04598-3

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Meanwhile, 87.5% of patients treated with EST reported at least some degree of symptoms improvement. Studies (8)(9)(10)14,(16)(17)(18)(19) have reported in the range Short title: Foam sclerotherapy with STS in arteriovenous malformations Running title: Foam STS in arteriovenous malformations of 40-80% of improvement in symptoms after successful EST. However, this was one of the very few studies, if any, to demonstrate that foam sclerotherapy with STS 3% was efficacious and safe to treat AVM, and therefore, could be used as an alternative to other sclerosants including ethanol.…”

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of embolo-sclerotherapy of arteriovenous malformations with foam sodium tetradecyl sulphate

et al. 2023

View full text Add to dashboard Cite

BACKGROUND:To evaluate the efficacy and safety of embolo-sclerotherapy (EST) particularly with foamed sclerotherapy in the treatment of arteriovenous malformations (AVMs). METHODS:All patients with AVM who underwent interventional therapy i.e. EST from January 1 st , 2015 -December 31 st , 2019 were identified through a prospective database. Types of AVM were classified according to Schobinger's classification. The outcome measures assessed efficacy and complications. The former was divided into four groups: no response, mild response, moderate response, and complete response.. Complications were defined as any tissue or functional damage, distal embolization or tissue reaction. Continuous variables were compared using analysis of variance (ANOVA) F test and discrete variables were analysed using Chisquared tests. P<0.05 was considered significant. RESULTS:A total of 65 patients were included. There was no statistical difference amongst the volume of foam STS 3% or alcohol used across all types of AVM. Overall, majority of patients (86.2%) reported some degree of improvement following interventional therapy. Six (9.2%) patients experienced complications including necrosis and amputation. The proportions of complication were significantly different across the categories (p=0.009). Patients with type III AVM seemed to report more complications than others.

show abstract